AFCM
Applied Finance Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.1M | Buy |
22,983
+3,190
| +16% | +$1.67M | 0.82% | 47 |
|
|
2025
Q1 | $12.6M | Sell |
19,793
-8,524
| -30% | -$5.41M | 0.92% | 46 |
|
|
2024
Q4 | $20.2M | Buy |
28,317
+54
| +0.2% | +$38.5K | 0.88% | 51 |
|
|
2024
Q3 | $29.7M | Sell |
28,263
-1,890
| -6% | -$1.99M | 1.27% | 40 |
|
|
2024
Q2 | $31.7M | Buy |
30,153
+8,000
| +36% | +$8.41M | 1.47% | 31 |
|
|
2024
Q1 | $21.3M | Sell |
22,153
-132
| -0.6% | -$127K | 1.5% | 40 |
|
|
2023
Q4 | $19.6M | Buy |
22,285
+1,803
| +9% | +$1.58M | 1.7% | 32 |
|
|
2023
Q3 | $16.9M | Buy |
20,482
+1,738
| +9% | +$1.43M | 1.83% | 26 |
|
|
2023
Q2 | $13.5M | Sell |
18,744
-2,333
| -11% | -$1.68M | 1.53% | 38 |
|
|
2023
Q1 | $17.3M | Buy |
21,077
+222
| +1% | +$182K | 2.15% | 15 |
|
|
2022
Q4 | $15M | Buy |
+20,855
| New | +$15M | 1.96% | 21 |
|